285 related articles for article (PubMed ID: 31178121)
1. A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.
Wojtaszek JL; Chatterjee N; Najeeb J; Ramos A; Lee M; Bian K; Xue JY; Fenton BA; Park H; Li D; Hemann MT; Hong J; Walker GC; Zhou P
Cell; 2019 Jun; 178(1):152-159.e11. PubMed ID: 31178121
[TBL] [Abstract][Full Text] [Related]
2. REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks.
Chatterjee N; Whitman MA; Harris CA; Min SM; Jonas O; Lien EC; Luengo A; Vander Heiden MG; Hong J; Zhou P; Hemann MT; Walker GC
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28918-28921. PubMed ID: 33168727
[TBL] [Abstract][Full Text] [Related]
3. The vital role of polymerase ζ and REV1 in mutagenic, but not correct, DNA synthesis across benzo[a]pyrene-dG and recruitment of polymerase ζ by REV1 to replication-stalled site.
Hashimoto K; Cho Y; Yang IY; Akagi J; Ohashi E; Tateishi S; de Wind N; Hanaoka F; Ohmori H; Moriya M
J Biol Chem; 2012 Mar; 287(12):9613-22. PubMed ID: 22303021
[TBL] [Abstract][Full Text] [Related]
4. REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.
Taglialatela A; Leuzzi G; Sannino V; Cuella-Martin R; Huang JW; Wu-Baer F; Baer R; Costanzo V; Ciccia A
Mol Cell; 2021 Oct; 81(19):4008-4025.e7. PubMed ID: 34508659
[TBL] [Abstract][Full Text] [Related]
5. Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction.
Sail V; Rizzo AA; Chatterjee N; Dash RC; Ozen Z; Walker GC; Korzhnev DM; Hadden MK
ACS Chem Biol; 2017 Jul; 12(7):1903-1912. PubMed ID: 28541665
[TBL] [Abstract][Full Text] [Related]
6. Roles of mutagenic translesion synthesis in mammalian genome stability, health and disease.
Jansen JG; Tsaalbi-Shtylik A; de Wind N
DNA Repair (Amst); 2015 May; 29():56-64. PubMed ID: 25655219
[TBL] [Abstract][Full Text] [Related]
7. A stapled POL κ peptide targets REV1 to inhibit mutagenic translesion synthesis.
Chatterjee N; D'Souza S; Shabab M; Harris CA; Hilinski GJ; Verdine GL; Walker GC
Environ Mol Mutagen; 2020 Oct; 61(8):830-836. PubMed ID: 32573829
[TBL] [Abstract][Full Text] [Related]
8. [Structural Basis of the Multifunctional Hub Protein and Identification of a Small-molecule Compound for Drug Discovery].
Hara K
Yakugaku Zasshi; 2019; 139(7):969-973. PubMed ID: 31257254
[TBL] [Abstract][Full Text] [Related]
9. Rev7 dimerization is important for assembly and function of the Rev1/Polζ translesion synthesis complex.
Rizzo AA; Vassel FM; Chatterjee N; D'Souza S; Li Y; Hao B; Hemann MT; Walker GC; Korzhnev DM
Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8191-E8200. PubMed ID: 30111544
[TBL] [Abstract][Full Text] [Related]
10. Implications of inhibition of Rev1 interaction with Y family DNA polymerases for cisplatin chemotherapy.
Yoon JH; Johnson RE; Prakash L; Prakash S
Genes Dev; 2021 Sep; 35(17-18):1256-1270. PubMed ID: 34385260
[TBL] [Abstract][Full Text] [Related]
11. Disrupting the MAD2L2-Rev1 Complex Enhances Cell Death upon DNA Damage.
Pernicone N; Elias M; Onn I; Tobi D; Listovsky T
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163901
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ, and Pol κ.
Wojtaszek J; Lee CJ; D'Souza S; Minesinger B; Kim H; D'Andrea AD; Walker GC; Zhou P
J Biol Chem; 2012 Sep; 287(40):33836-46. PubMed ID: 22859295
[TBL] [Abstract][Full Text] [Related]
13. Error-prone translesion synthesis mediates acquired chemoresistance.
Xie K; Doles J; Hemann MT; Walker GC
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20792-7. PubMed ID: 21068378
[TBL] [Abstract][Full Text] [Related]
14. Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer.
Vassel FM; Bian K; Walker GC; Hemann MT
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28922-28924. PubMed ID: 33144509
[TBL] [Abstract][Full Text] [Related]
15. Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polζ Suggests a Mechanism of Polymerase Exchange upon Rev1/Polζ-Dependent Translesion Synthesis.
Pustovalova Y; Magalhães MT; D'Souza S; Rizzo AA; Korza G; Walker GC; Korzhnev DM
Biochemistry; 2016 Apr; 55(13):2043-53. PubMed ID: 26982350
[TBL] [Abstract][Full Text] [Related]
16. DNA polymerase eta: A potential pharmacological target for cancer therapy.
Saha P; Mandal T; Talukdar AD; Kumar D; Kumar S; Tripathi PP; Wang QE; Srivastava AK
J Cell Physiol; 2021 Jun; 236(6):4106-4120. PubMed ID: 33184862
[TBL] [Abstract][Full Text] [Related]
17. Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis.
Guo C; Fischhaber PL; Luk-Paszyc MJ; Masuda Y; Zhou J; Kamiya K; Kisker C; Friedberg EC
EMBO J; 2003 Dec; 22(24):6621-30. PubMed ID: 14657033
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted recognition of vertebrate Rev1 by translesion polymerases ζ and κ.
Wojtaszek J; Liu J; D'Souza S; Wang S; Xue Y; Walker GC; Zhou P
J Biol Chem; 2012 Jul; 287(31):26400-8. PubMed ID: 22700975
[TBL] [Abstract][Full Text] [Related]
19. Proteasomal regulation of the mutagenic translesion DNA polymerase, Saccharomyces cerevisiae Rev1.
Wiltrout ME; Walker GC
DNA Repair (Amst); 2011 Feb; 10(2):169-75. PubMed ID: 21227758
[TBL] [Abstract][Full Text] [Related]
20. REV1-POL ζ Inhibition and Cancer Therapy.
Taniguchi T
Mol Cell; 2019 Aug; 75(3):419-420. PubMed ID: 31398321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
